Quinalizarin as a potential antifungal drug for the treatment of Candida albicans fungal infection in cancer patients

Quinalizarin as a potential antifungal drug for the treatment of Candida albicans fungal infection in cancer patients

ABSTRACTThis study aims to analyze the antifungal properties of quinalizarin, a plant-derived compound with proven anticancer effects. Quinalizarin exhibited antifungal activity against opportunistic pathogenic Candida species and Geotrichum capitatum. The treatment with this anthraquinone reduced h...

Full description

Bibliographic Details
Main Authors: Monika Janeczko, Elżbieta Kochanowicz, Kamila Górka, Tomasz Skrzypek
Format: Article
Language:English
Published: American Society for Microbiology 2024-03-01
Series:Microbiology Spectrum
Subjects:
antifungal activity
anthraquinones
biofilm
Candida albicans
Candida auris
cancer
Online Access:https://journals.asm.org/doi/10.1128/spectrum.03652-23

Internet

https://journals.asm.org/doi/10.1128/spectrum.03652-23

Similar Items